May 29, 2008
Story Timeline: 189 days
WASHINGTON----The Medicines Company today announced that its investigational agent, CleviprexTM injectable emulsion was well tolerated in elderly patients and rapidly achieved and maintained blood pressure control in patients presenting to the emergency department or intensive care unit with...
[read full story]